Tango Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 13.06 M | $115.72 M | 21.42% | 11.77% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 12.76 M | $113.07 M | 49.51% | 11.50% |
| BOXER CAPITAL MANAGEMENT, LLC | 02/17/2026 | 10.88 M | $96.36 M | 11.31% | 9.80% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 10.61 M | $93.99 M | 322.46% | 9.56% |
| WOODLINE PARTNERS LP | 02/17/2026 | 10.07 M | $89.24 M | 67.04% | 9.08% |
| BLACKROCK, INC. | 02/12/2026 | 8.54 M | $75.67 M | 51.25% | 7.70% |
| SIREN, L.L.C. | 02/13/2026 | 8.17 M | $72.35 M | 38.79% | 7.36% |
| TRV GP IV, LLC | 02/13/2026 | 7.87 M | $69.77 M | -43.20% | 7.10% |
| NEXTECH INVEST, LTD. | 02/17/2026 | 7.27 M | $64.38 M | 31.30% | 6.55% |
| VANGUARD GROUP INC | 01/29/2026 | 6.75 M | $59.81 M | 33.63% | 6.08% |
| STATE STREET CORP | 02/13/2026 | 6.22 M | $55.10 M | 84.79% | 5.60% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 5.28 M | $46.77 M | 52.02% | 4.76% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 4.94 M | $43.79 M | 227.43% | 4.45% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 4.20 M | $37.21 M | 342.11% | 3.78% |
| BELLEVUE GROUP AG | 02/17/2026 | 3.93 M | $34.80 M | 100.00% | 3.54% |
| CALIGAN PARTNERS LP | 02/17/2026 | 3.73 M | $33.05 M | 100.00% | 3.36% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 3.57 M | $31.65 M | 97.39% | 3.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 2.91 M | $25.76 M | 100.00% | 2.62% |
| FMR LLC | 02/17/2026 | 2.87 M | $25.41 M | 44,524.15% | 2.58% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 2.66 M | $23.59 M | 100.00% | 2.40% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 2.64 M | $23.47 M | 14.85% | 2.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.55 M | $22.63 M | 35.63% | 2.30% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 2.45 M | $21.75 M | 68.75% | 2.21% |
| VIVO CAPITAL, LLC | 02/13/2026 | 2.15 M | $19.09 M | 177.43% | 1.94% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.97 M | $17.49 M | -32.38% | 1.78% |
| RTW INVESTMENTS, LP | 02/17/2026 | 1.49 M | $13.21 M | 100.00% | 1.34% |
| MORGAN STANLEY | 02/13/2026 | 1.42 M | $12.60 M | 464.67% | 1.28% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 1.40 M | $12.39 M | 50.83% | 1.26% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.03 M | $9.09 M | 138.29% | 0.92% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 1.00 M | $8.86 M | 100.00% | 0.90% |
| UBS GROUP AG | 01/29/2026 | 990.46 K | $8.78 M | 517.19% | 0.89% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 957.28 K | $8.48 M | 100.00% | 0.86% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 840.99 K | $7.45 M | 27.75% | 0.76% |
| NORTHERN TRUST CORP | 02/17/2026 | 803.20 K | $7.12 M | 32.64% | 0.72% |
| CANDRIAM S.C.A. | 04/30/2026 | 708.81 K | $6.28 M | 0.00% | 0.64% |
| BESSEMER GROUP INC | 02/05/2026 | 708.40 K | $6.28 M | 0.00% | 0.64% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/17/2026 | 708.39 K | $6.28 M | 0.00% | 0.64% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/17/2026 | 653.49 K | $5.79 M | -75.90% | 0.59% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 593.00 K | $5.25 M | -54.22% | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 544.56 K | $4.82 M | 100.00% | 0.49% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 513.04 K | $4.55 M | 100.00% | 0.46% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 487.08 K | $4.32 M | -27.60% | 0.44% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 478.06 K | $4.24 M | 207.54% | 0.43% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 446.21 K | $3.95 M | -87.35% | 0.40% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 386.92 K | $3.43 M | 100.00% | 0.35% |
| BARCLAYS PLC | 02/13/2026 | 368.19 K | $3.26 M | 0.69% | 0.33% |
| MASS GENERAL BRIGHAM, INC | 01/27/2026 | 354.19 K | $3.14 M | 100.00% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 343.84 K | $3.05 M | 78.76% | 0.31% |
| MARSHALL WACE, LLP | 02/13/2026 | 329.23 K | $2.92 M | -77.90% | 0.30% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 318.68 K | $2.82 M | 100.00% | 0.29% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tango Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 213 institutional investors and hedge funds held shares of Tango Therapeutics Inc. The most heavily invested institutionals were:
Candriam S.C.A.: 1.27 M
UBS Group AG: 699,352
Nuveen, LLC: 360,818
Mass General Brigham, Inc: 354,192
CONGRESS ASSET MANAGEMENT CO /MA: 341,361
Bank of New York Mellon Corp: 318,458
155.35% of Tango Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 191.68 M shares in the last 24 months. This purchase volume represents approximately $3.15 B in transactions.